<?xml version="1.0" encoding="UTF-8"?>
<p id="Par55">While mAbs are routinely used in biochemistry, molecular and cellular biology, and medical research, perhaps the most beneficial application is their use as therapeutic drugs for the treatment of human diseases, such as cancer, asthma, arthritis, psoriasis, Crohnâ€™s disease, transplant rejection, migraine headaches and infectious diseases (Table 
 <xref rid="Tab1" ref-type="table">1</xref>). Important advances in antibody engineering made over the past decade have enhanced the safety and efficacy of the therapeutic antibodies. These developments, along with a greater understanding of the immunomodulatory properties of antibodies, have paved the way for the next generation of new and improved antibody-based drugs for the treatment of human diseases.
</p>
